_id
691727313c536f8df2316be4
Ticker
UTRS
Name
Minerva Surgical Inc
Exchange
PINK
Address
4255 Burton Drive, Santa Clara, CA, United States, 95054
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://minervasurgical.com
Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Last Close
0.0001
Volume
-
Current Price
0.0002
Change
0
Last Updated
2026-01-07T13:59:41.852Z
Image
https://logo.clearbit.com/minervasurgical.com
Ipo Date
2021-10-22T00:00:00.000Z
Market Cap
887
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
3
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2023-09-30
Revenue
11965000
Cost Of Revenue
5747000
Gross Profit
6218000
Operating Expenses
12314000
Operating Income
-6096000
Interest Expense
1172000
Pretax Income
-7178000
Net Income
-7181000
Eps
-0.8093093225085817
Dividends Per Share
-
Shares Outstanding
8878582
Income Tax Expense
3000
EBITDA
-4560000
Operating Margin
-50.9486000835771
Total Other Income Expense Net
-1082000
Cash
11125000
Short Term Investments
-
Receivables
7569000
Inventories
18183000
Total Current Assets
40002000
Property Plant Equipment
9423000
Total Assets
72785000
Payables
3036000
Short Term Debt
12272000
Long Term Debt
27885000
Total Liabilities
52530000
Equity
20255000
Bs_currency_symbol
USD
Depreciation
1446000
Change In Working Capital
-775000
Cash From Operations
-5095000
Capital Expenditures
17000
Cash From Investing
-17000
Cash From Financing
0
Net Change In Cash
-5112000
Cf_currency_symbol
USD
PE
-
PB
0.00008761291532954827
ROE
-35.452974574179215
ROA
-9.866043827711755
FCF
-5112000
Fcf Percent
-0.4272461345591308
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
11965000
Quarters > 0 > income Statement > cost Of Revenue
5747000
Quarters > 0 > income Statement > gross Profit
6218000
Quarters > 0 > income Statement > operating Expenses
12314000
Quarters > 0 > income Statement > operating Income
-6096000
Quarters > 0 > income Statement > interest Expense
1172000
Quarters > 0 > income Statement > pretax Income
-7178000
Quarters > 0 > income Statement > net Income
-7181000
Quarters > 0 > income Statement > eps
-0.8093093225085817
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8872998
Quarters > 0 > income Statement > income Tax Expense
3000
Quarters > 0 > income Statement > EBITDA
-4560000
Quarters > 0 > income Statement > operating Margin
-50.9486000835771
Quarters > 0 > income Statement > total Other Income Expense Net
-1082000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
11125000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7569000
Quarters > 0 > balance Sheet > inventories
18183000
Quarters > 0 > balance Sheet > total Current Assets
40002000
Quarters > 0 > balance Sheet > property Plant Equipment
9423000
Quarters > 0 > balance Sheet > total Assets
72785000
Quarters > 0 > balance Sheet > payables
3036000
Quarters > 0 > balance Sheet > short Term Debt
12272000
Quarters > 0 > balance Sheet > long Term Debt
27885000
Quarters > 0 > balance Sheet > total Liabilities
52530000
Quarters > 0 > balance Sheet > equity
20255000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7181000
Quarters > 0 > cash Flow > depreciation
1446000
Quarters > 0 > cash Flow > change In Working Capital
-775000
Quarters > 0 > cash Flow > cash From Operations
-5095000
Quarters > 0 > cash Flow > capital Expenditures
17000
Quarters > 0 > cash Flow > cash From Investing
-17000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-5112000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.8093093225085817
Quarters > 0 > ratios > PB
0.00008761291532954827
Quarters > 0 > ratios > ROE
-35.452974574179215
Quarters > 0 > ratios > ROA
-9.866043827711755
Quarters > 0 > ratios > FCF
-5112000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.4272461345591308
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
13391000
Quarters > 1 > income Statement > cost Of Revenue
5989000
Quarters > 1 > income Statement > gross Profit
7402000
Quarters > 1 > income Statement > operating Expenses
15060000
Quarters > 1 > income Statement > operating Income
-7658000
Quarters > 1 > income Statement > interest Expense
1129000
Quarters > 1 > income Statement > pretax Income
-8642000
Quarters > 1 > income Statement > net Income
-8681000
Quarters > 1 > income Statement > eps
-0.9810496157282561
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8848686
Quarters > 1 > income Statement > income Tax Expense
39000
Quarters > 1 > income Statement > EBITDA
-5530000
Quarters > 1 > income Statement > operating Margin
-57.187663355985364
Quarters > 1 > income Statement > total Other Income Expense Net
-984000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
15713000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
7945000
Quarters > 1 > balance Sheet > inventories
17881000
Quarters > 1 > balance Sheet > total Current Assets
46082000
Quarters > 1 > balance Sheet > property Plant Equipment
9515000
Quarters > 1 > balance Sheet > total Assets
79303000
Quarters > 1 > balance Sheet > payables
3819000
Quarters > 1 > balance Sheet > short Term Debt
8987000
Quarters > 1 > balance Sheet > long Term Debt
31075000
Quarters > 1 > balance Sheet > total Liabilities
52716000
Quarters > 1 > balance Sheet > equity
26587000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-8681000
Quarters > 1 > cash Flow > depreciation
1983000
Quarters > 1 > cash Flow > change In Working Capital
-3983000
Quarters > 1 > cash Flow > cash From Operations
-9608000
Quarters > 1 > cash Flow > capital Expenditures
13000
Quarters > 1 > cash Flow > cash From Investing
-13000
Quarters > 1 > cash Flow > cash From Financing
79000
Quarters > 1 > cash Flow > net Change In Cash
-9542000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.9810496157282561
Quarters > 1 > ratios > PB
0.00006656400496483244
Quarters > 1 > ratios > ROE
-32.6512957460413
Quarters > 1 > ratios > ROA
-10.946622448078887
Quarters > 1 > ratios > FCF
-9621000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.7184676275110149
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
12533000
Quarters > 2 > income Statement > cost Of Revenue
5518000
Quarters > 2 > income Statement > gross Profit
7015000
Quarters > 2 > income Statement > operating Expenses
17325000
Quarters > 2 > income Statement > operating Income
-10310000
Quarters > 2 > income Statement > interest Expense
1068000
Quarters > 2 > income Statement > pretax Income
-11343000
Quarters > 2 > income Statement > net Income
-13444000
Quarters > 2 > income Statement > eps
-2.8133209617523116
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4778694
Quarters > 2 > income Statement > income Tax Expense
11000
Quarters > 2 > income Statement > EBITDA
-10240000
Quarters > 2 > income Statement > operating Margin
-82.26282613899306
Quarters > 2 > income Statement > total Other Income Expense Net
-1033000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
25255000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
7392000
Quarters > 2 > balance Sheet > inventories
17195000
Quarters > 2 > balance Sheet > total Current Assets
54111000
Quarters > 2 > balance Sheet > property Plant Equipment
5484000
Quarters > 2 > balance Sheet > total Assets
85168000
Quarters > 2 > balance Sheet > payables
3690000
Quarters > 2 > balance Sheet > short Term Debt
5282000
Quarters > 2 > balance Sheet > long Term Debt
34260000
Quarters > 2 > balance Sheet > total Liabilities
51097000
Quarters > 2 > balance Sheet > equity
34071000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-11343000
Quarters > 2 > cash Flow > depreciation
2514000
Quarters > 2 > cash Flow > change In Working Capital
-1056000
Quarters > 2 > cash Flow > cash From Operations
-8386000
Quarters > 2 > cash Flow > capital Expenditures
75000
Quarters > 2 > cash Flow > cash From Investing
-75000
Quarters > 2 > cash Flow > cash From Financing
26774000
Quarters > 2 > cash Flow > net Change In Cash
18313000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.8133209617523116
Quarters > 2 > ratios > PB
0.000028051386809896982
Quarters > 2 > ratios > ROE
-39.458777259252734
Quarters > 2 > ratios > ROA
-15.785271463460454
Quarters > 2 > ratios > FCF
-8461000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.6750977419612224
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
13804000
Quarters > 3 > income Statement > cost Of Revenue
6433000
Quarters > 3 > income Statement > gross Profit
7371000
Quarters > 3 > income Statement > operating Expenses
12563000
Quarters > 3 > income Statement > operating Income
-5192000
Quarters > 3 > income Statement > interest Expense
1026000
Quarters > 3 > income Statement > pretax Income
-6234000
Quarters > 3 > income Statement > net Income
-6245000
Quarters > 3 > income Statement > eps
-0.21117997257737597
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
29571933
Quarters > 3 > income Statement > income Tax Expense
11000
Quarters > 3 > income Statement > EBITDA
-5208000
Quarters > 3 > income Statement > operating Margin
-37.61228629382787
Quarters > 3 > income Statement > total Other Income Expense Net
-1042000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6942000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
7244000
Quarters > 3 > balance Sheet > inventories
16850000
Quarters > 3 > balance Sheet > total Current Assets
36119000
Quarters > 3 > balance Sheet > property Plant Equipment
5312000
Quarters > 3 > balance Sheet > total Assets
68900000
Quarters > 3 > balance Sheet > payables
2804000
Quarters > 3 > balance Sheet > short Term Debt
2249000
Quarters > 3 > balance Sheet > long Term Debt
37441000
Quarters > 3 > balance Sheet > total Liabilities
51719000
Quarters > 3 > balance Sheet > equity
17181000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-6245000
Quarters > 3 > cash Flow > depreciation
2753000
Quarters > 3 > cash Flow > change In Working Capital
-9201000
Quarters > 3 > cash Flow > cash From Operations
-15644000
Quarters > 3 > cash Flow > capital Expenditures
36000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2000
Quarters > 3 > cash Flow > net Change In Cash
-15590000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.21117997257737597
Quarters > 3 > ratios > PB
0.000344239951108783
Quarters > 3 > ratios > ROE
-36.34829171759502
Quarters > 3 > ratios > ROA
-9.063860667634252
Quarters > 3 > ratios > FCF
-15680000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.1359026369168357
Quarters > 3 > health Score
15
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
51693000
Annuals > 0 > income Statement > cost Of Revenue
23687000
Annuals > 0 > income Statement > gross Profit
28006000
Annuals > 0 > income Statement > operating Expenses
80949000
Annuals > 0 > income Statement > operating Income
-29256000
Annuals > 0 > income Statement > interest Expense
4395000
Annuals > 0 > income Statement > pretax Income
-33397000
Annuals > 0 > income Statement > net Income
-33450000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-56.59567059369741
Annuals > 0 > income Statement > total Other Income Expense Net
-42000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-33450000
Annuals > 0 > cash Flow > depreciation
8696000
Annuals > 0 > cash Flow > change In Working Capital
-15015000
Annuals > 0 > cash Flow > cash From Operations
-38733000
Annuals > 0 > cash Flow > capital Expenditures
53000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
26855000
Annuals > 0 > cash Flow > net Change In Cash
-11931000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-38786000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.7503143559089238
Annuals > 0 > health Score
38
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
50294000
Annuals > 1 > income Statement > cost Of Revenue
23052000
Annuals > 1 > income Statement > gross Profit
27242000
Annuals > 1 > income Statement > operating Expenses
58141000
Annuals > 1 > income Statement > operating Income
-30899000
Annuals > 1 > income Statement > interest Expense
3222000
Annuals > 1 > income Statement > pretax Income
-34101000
Annuals > 1 > income Statement > net Income
-34112000
Annuals > 1 > income Statement > eps
-23.681948762237734
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1440422
Annuals > 1 > income Statement > income Tax Expense
11000
Annuals > 1 > income Statement > EBITDA
-20073000
Annuals > 1 > income Statement > operating Margin
-61.43675189883485
Annuals > 1 > income Statement > total Other Income Expense Net
-3202000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6942000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
7244000
Annuals > 1 > balance Sheet > inventories
16850000
Annuals > 1 > balance Sheet > total Current Assets
36119000
Annuals > 1 > balance Sheet > property Plant Equipment
5312000
Annuals > 1 > balance Sheet > total Assets
68900000
Annuals > 1 > balance Sheet > payables
2804000
Annuals > 1 > balance Sheet > short Term Debt
2249000
Annuals > 1 > balance Sheet > long Term Debt
37441000
Annuals > 1 > balance Sheet > total Liabilities
51719000
Annuals > 1 > balance Sheet > equity
17181000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-34112000
Annuals > 1 > cash Flow > depreciation
10806000
Annuals > 1 > cash Flow > change In Working Capital
-11053000
Annuals > 1 > cash Flow > cash From Operations
-35567000
Annuals > 1 > cash Flow > capital Expenditures
73000
Annuals > 1 > cash Flow > cash From Investing
-73000
Annuals > 1 > cash Flow > cash From Financing
-4964000
Annuals > 1 > cash Flow > net Change In Cash
-40604000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-23.681948762237734
Annuals > 1 > ratios > PB
0.000008383807694546302
Annuals > 1 > ratios > ROE
-198.54490425469996
Annuals > 1 > ratios > ROA
-49.50943396226415
Annuals > 1 > ratios > FCF
-35640000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.7086332365689745
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
52103000
Annuals > 2 > income Statement > cost Of Revenue
21580000
Annuals > 2 > income Statement > gross Profit
30523000
Annuals > 2 > income Statement > operating Expenses
59668000
Annuals > 2 > income Statement > operating Income
-29145000
Annuals > 2 > income Statement > interest Expense
11728000
Annuals > 2 > income Statement > pretax Income
-21455000
Annuals > 2 > income Statement > net Income
-21464000
Annuals > 2 > income Statement > eps
-14.982800214438885
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1432576
Annuals > 2 > income Statement > income Tax Expense
9000
Annuals > 2 > income Statement > EBITDA
893000
Annuals > 2 > income Statement > operating Margin
-55.93727808379556
Annuals > 2 > income Statement > total Other Income Expense Net
7690000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
40608000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
7292000
Annuals > 2 > balance Sheet > inventories
15682000
Annuals > 2 > balance Sheet > total Current Assets
75004000
Annuals > 2 > balance Sheet > property Plant Equipment
4594000
Annuals > 2 > balance Sheet > total Assets
115092000
Annuals > 2 > balance Sheet > payables
3629000
Annuals > 2 > balance Sheet > short Term Debt
189000
Annuals > 2 > balance Sheet > long Term Debt
39274000
Annuals > 2 > balance Sheet > total Liabilities
70988000
Annuals > 2 > balance Sheet > equity
44104000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-21464000
Annuals > 2 > cash Flow > depreciation
10620000
Annuals > 2 > cash Flow > change In Working Capital
-8549000
Annuals > 2 > cash Flow > cash From Operations
-22379000
Annuals > 2 > cash Flow > capital Expenditures
584000
Annuals > 2 > cash Flow > cash From Investing
-25584000
Annuals > 2 > cash Flow > cash From Financing
71212000
Annuals > 2 > cash Flow > net Change In Cash
23249000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-14.982800214438885
Annuals > 2 > ratios > PB
0.0000032481770360964993
Annuals > 2 > ratios > ROE
-48.66678759296209
Annuals > 2 > ratios > ROA
-18.649428283460185
Annuals > 2 > ratios > FCF
-22963000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.4407231829261271
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
37768000
Annuals > 3 > income Statement > cost Of Revenue
18648000
Annuals > 3 > income Statement > gross Profit
19120000
Annuals > 3 > income Statement > operating Expenses
34510000
Annuals > 3 > income Statement > operating Income
-15390000
Annuals > 3 > income Statement > interest Expense
12140000
Annuals > 3 > income Statement > pretax Income
-18395000
Annuals > 3 > income Statement > net Income
-18263000
Annuals > 3 > income Statement > eps
-17.90565680710069
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1019957
Annuals > 3 > income Statement > income Tax Expense
-132000
Annuals > 3 > income Statement > EBITDA
821000
Annuals > 3 > income Statement > operating Margin
-40.748782037703876
Annuals > 3 > income Statement > total Other Income Expense Net
-3005000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
17359000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8379000
Annuals > 3 > balance Sheet > inventories
10201000
Annuals > 3 > balance Sheet > total Current Assets
45421000
Annuals > 3 > balance Sheet > property Plant Equipment
2880000
Annuals > 3 > balance Sheet > total Assets
92046000
Annuals > 3 > balance Sheet > payables
3506000
Annuals > 3 > balance Sheet > short Term Debt
1668000
Annuals > 3 > balance Sheet > long Term Debt
95619000
Annuals > 3 > balance Sheet > total Liabilities
313857000
Annuals > 3 > balance Sheet > equity
-221811000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-18263000
Annuals > 3 > cash Flow > depreciation
7076000
Annuals > 3 > cash Flow > change In Working Capital
-2865000
Annuals > 3 > cash Flow > cash From Operations
-12241000
Annuals > 3 > cash Flow > capital Expenditures
453000
Annuals > 3 > cash Flow > cash From Investing
-15453000
Annuals > 3 > cash Flow > cash From Financing
18077000
Annuals > 3 > cash Flow > net Change In Cash
-9617000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-17.90565680710069
Annuals > 3 > ratios > PB
-4.5983156831717094e-7
Annuals > 3 > ratios > ROE
8.233586251358139
Annuals > 3 > ratios > ROA
-19.841166373335074
Annuals > 3 > ratios > FCF
-12694000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.33610463884770175
Annuals > 3 > health Score
21
Valuation > metrics > PE
-0.8093093225085817
Valuation > metrics > PB
0.00008761291532954827
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-35.452974574179215
Profitability > metrics > ROA
-17.951602419879006
Profitability > metrics > Net Margin
-0.6001671541997493
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.5934337200691187
Risk > metrics > Interest Coverage
-5.201365187713311
Risk > final Score
-3
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.6131434544029264
Liquidity > metrics > Quick Ratio
1.4253331591324798
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
3
Prev Risks > 1
-9
Prev Risks > 2
-14
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:46:02.328Z
Earnings History > 0 > period
2023-09-30
Earnings History > 0 > report Date
2023-11-13
Earnings History > 0 > date
2023-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.81
Earnings History > 0 > eps Estimate
-1
Earnings History > 0 > eps Difference
0.19
Earnings History > 0 > surprise Percent
19
Earnings History > 1 > period
2023-06-30
Earnings History > 1 > report Date
2023-08-02
Earnings History > 1 > date
2023-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.05
Earnings History > 1 > eps Estimate
-0.09
Earnings History > 1 > eps Difference
0.04
Earnings History > 1 > surprise Percent
44.4444
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-05-02
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.12
Earnings History > 2 > eps Estimate
-0.11
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-9.0909
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-22
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-0.21
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
4.7619
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-11-14
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4
Earnings History > 4 > eps Estimate
-0.28
Earnings History > 4 > eps Difference
-0.12
Earnings History > 4 > surprise Percent
-42.8571
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-08-09
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2
Earnings History > 5 > eps Estimate
-0.34
Earnings History > 5 > eps Difference
0.14
Earnings History > 5 > surprise Percent
41.1765
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-05-11
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.38
Earnings History > 6 > eps Estimate
-0.31
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-22.5806
Earnings History > 7 > period
2021-12-31
Earnings History > 7 > report Date
2022-03-08
Earnings History > 7 > date
2021-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.26
Earnings History > 7 > eps Estimate
-0.29
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
10.3448
Earnings History > 8 > period
2021-09-30
Earnings History > 8 > report Date
2021-12-02
Earnings History > 8 > date
2021-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
4.87
Earnings History > 8 > eps Estimate
-0.44
Earnings History > 8 > eps Difference
5.31
Earnings History > 8 > surprise Percent
1206.8182
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-09-01
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.586
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.586
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-06-30
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.9035
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.9035
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-12-31
Earnings History > 11 > report Date
2021-03-31
Earnings History > 11 > date
2020-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-2.112
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-2.112
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-12-31
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-1.1206
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-1.1206
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-06-30
Earnings History > 13 > report Date
2020-09-30
Earnings History > 13 > date
2020-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.1206
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-1.1206
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-03-31
Earnings History > 14 > report Date
2020-06-30
Earnings History > 14 > date
2020-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.8612
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.8612
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-12-31
Earnings History > 15 > report Date
2020-03-31
Earnings History > 15 > date
2019-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0458
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0458
Earnings History > 15 > surprise Percent
-
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AT2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review Defense World
Read more →Showing 2 of 8
(Last Updated 2023-09-30)
Rating:
BUY
Target Price:
$3
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2023-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.01% of the total shares of Minerva Surgical Inc
1.
Northern Trust Extended Eq Market Idx(0.0025%)
since
2023/12/31
2.
NT Ext Equity Mkt Idx Fd - L(0.0025%)
since
2023/12/31
3.
Susquehanna International Group, LLP(0%)
since
2023/09/30
4.
Morgan Stanley - Brokerage Accounts(0%)
since
2023/09/30
5.
Cubist Systematic Strategies, LLC(0%)
since
2023/09/30
6.
UBS Group AG(0%)
since
2023/09/30
7.
BNYM Mellon NSL Mkt Completion Fund Inst(0%)
since
2023/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-09-30
EPS Actual
-0.81
EPS Estimate
-1
EPS Difference
0.19
Surprise Percent
19%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.